Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 12, 2020 |
| Target | Vernalis |
| Sector | Life Science |
| Buyer(s) | HitGen |
| Sellers(s) | Ligand Pharmaceuticals |
| Deal Type | Divestiture |
| Deal Value | 25M USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2012 |
| Sector | Life Science |
| Employees | 492 |
| Revenue | 427M CNY (2024) |
HitGen is a biotech company for early-stage drug discovery research, centered on DNA-encoded chemical libraries (DELs). HitGen’s DELs include encoded syntheses for hundreds of billions of novel, diverse, drug-like small molecule and macrocycle compounds. These compounds are members of DELs synthesized from many hundreds of distinct chemical scaffolds, designed and assembled with tractable chemistry based on proven results for identifying drug-like leads against biological targets from known and novel classes. HitGen is working with multiple pharmaceutical and biotech companies, foundations, and research institutes in North America, Europe, Australia, and Asia to discover and develop novel therapeutics of the future. HitGen was founded in 2012 and is based in Chengdu, China.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| Country: United Kingdom | 1 of 1 |
| Year: 2020 | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1987 |
| Sector | Life Science |
| Employees | 68 |
| Revenue | 167M USD (2024) |
Ligand Pharmaceuticals is a pharmaceutical company, develops products for men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand Pharmaceuticals was founded in 1987 and is based in Jupiter, Florida.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| Country: United Kingdom | 1 of 1 |
| Year: 2020 | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-09-10 |
Taurus Biosciences
San Diego, California, United States Taurus Biosciences LLC is a biotechnology company that discovers and develops novel cow antibodies. Cow antibodies have the longest CDR3s of any species, with unique genetic and structural diversity that can enable binding to challenging antigens. Taurus Biosciences is based in San Diego, California. |
Buy | $5M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-09-27 |
Novan
Durham, North Carolina, United States Novan is a specialty dermatology company focused on researching, developing, and marketing innovative therapeutic products for skin diseases. Novan was founded in 2006 and is based in Durham, North Carolina. |
Buy | $12M |
